medigraphic.com
ENGLISH

Revista Médica del Instituto Mexicano del Seguro Social

  • Mostrar índice
  • Números disponibles
  • Información
    • Información general        
    • Directorio
  • Publicar
    • Instrucciones para autores        
  • medigraphic.com
    • Inicio
    • Índice de revistas            
    • Registro / Acceso
  • Mi perfil

2005, Número S1

<< Anterior Siguiente >>

Rev Med Inst Mex Seguro Soc 2005; 43 (S1)


¿Qué hacer cuando todas las unidades son incompatibles?

Garratty G
Texto completo Cómo citar este artículo Artículos similares

Idioma: Ingles.
Referencias bibliográficas: 17
Paginas: 107-111
Archivo PDF: 122.43 Kb.


PALABRAS CLAVE

Inmunohematología, trasfusion de eritrocitos.

RESUMEN

No tiene Resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Petz LD, Garratty G. Immune hemolytic anemias. Second edition. Philadelphia: Churchill Livingstone; 2004.

  2. Branch DR, Petz LD. Detecting alloantibodies in patients with autoantibodies. Transfusion 1999;39:6-10.

  3. Engelfriet CP, Reesink HW. The detection of alloanti-bodies against red cells in patients with warm-type autoimmune haemolytic anaemia. Vox Sang 2000;78: 200-7.

  4. Garratty G, Petz LD. Approaches to selecting blood for transfusion to patients with autoimmune hemolytic anemia. Transfusion 2000;42:1390-2.

  5. Leger RM, Garratty G. Evaluation of methods for detecting alloantibodies underlying warm auto-antibodies. Transfusion 1999;39:11-16.

  6. Brecher M, ed. Techncial manual. 15th ed. Bethesda, MD: American Association of Blood Banks; 2005.

  7. Oyen R, Angeles ML. A simple screening method to evaluate the presence of alloantibodies with concomitant warm autoantibodies. Immunohema-tology 1995;11:85-7.

  8. Leger RM, Garratty G. Weakening or loss of antibody reactivity after prewarm technique. Transfusion 2003;23:1611-14.

  9. Reid ME, Lomas-Francis C. The blood group antigen facts book. Second edition. New York: Academic Press, 2004.

  10. Garratty G. Predicting the clinical significance of red cell antibodies with in vitro cellular assays. Transfus Med Rev 1990;IV:297-312.

  11. Arndt PA, Garratty G. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies. Transfusion 2004;44:1273-81.

  12. Leger RM. In vitro cellular assays and other approaches used to predict the clinical significance of red cell alloantibodies: a review. Immunohematology 2002;18:65-70.

  13. Nance ST, Arndt PA. Review: what to dowhen all RBCs are incompatible – serologic aspects. Immuno-hematology 2004;20:147-60.

  14. International Committee for Standardization in Haema-tology. Recommended method for radioisotope red-cell survival studies. Br J Haematol 1980;45:659-55.

  15. Engelfriet CP, Ouwehand WH. ADCC and other cellular bioassays for predicting the clinical signifi-cance of red cell alloantibodies. Baillieres Clin Haematol 1990;3:321-37.

  16. Hadley A, Wilkes A, Poole J, Arndt P, Garratty G. A chemiluminescence test for predicting the outcome of transfusing incompatible blood. Transfus Med 1999;9:337-42.

  17. Leger R, Arndt P, Co A, O’Brien L, Garratty G. Clinical significance of an anti-Dib assessed by flow cytometry.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Inst Mex Seguro Soc. 2005;43

ARTíCULOS SIMILARES

CARGANDO ...